MR Volumetry of Lung Nodules: A Pilot Study. by Delacoste, J. et al.
BRIEF RESEARCH REPORT
published: 12 February 2019
doi: 10.3389/fmed.2019.00018
Frontiers in Medicine | www.frontiersin.org 1 February 2019 | Volume 6 | Article 18
Edited by:
Konrad E. Bloch,
University Hospital Zürich, Switzerland
Reviewed by:
Rudolf Maria Huber,
Ludwig Maximilian University of
Munich, Germany
Levent Dalar,
Istanbul Bilim University, Turkey
*Correspondence:
Catherine Beigelman-Aubry
catherine.beigelman-aubry@chuv.ch
Specialty section:
This article was submitted to
Pulmonary Medicine,
a section of the journal
Frontiers in Medicine
Received: 12 November 2018
Accepted: 21 January 2019
Published: 12 February 2019
Citation:
Delacoste J, Dunet V, Dournes G,
Lovis A, Rohner C, Elandoy C,
Simons J, Long O, Piccini D,
Stuber M, Prior JO, Nicod L and
Beigelman-Aubry C (2019) MR
Volumetry of Lung Nodules: A Pilot
Study. Front. Med. 6:18.
doi: 10.3389/fmed.2019.00018
MR Volumetry of Lung Nodules: A
Pilot Study
Jean Delacoste 1, Vincent Dunet 1, Gael Dournes 2,3,4, Alban Lovis 5, Chantal Rohner 1,
Christel Elandoy 1, Julien Simons 6, Olivier Long 6, Davide Piccini 1,7, Matthias Stuber 1,8,
John O. Prior 9, Laurent Nicod 5 and Catherine Beigelman-Aubry 1*
1Department of Radiology, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland, 2Centre
de Recherche Cardio-Thoracique de Bordeaux, Université de Bordeaux, Bordeaux, France, 3 Inserm, Centre de Recherche
Cardio-Thoracique de Bordeaux, Bordeaux, France, 4CHU de Bordeaux, Service d’Imagerie Thoracique et Cardiovasculaire,
Service des Maladies Respiratoires, Service d’Exploration Fonctionnelle Respiratoire, Pessac, France, 5 Service of
Pneumology, Department of Medicine, Lausanne University Hospital (CHUV), Lausanne, Switzerland, 6Department of
Physiotherapy, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland, 7 Advanced Clinical
Imaging Technology, Siemens Healthcare AG, Lausanne, Switzerland, 8Center for Biomedical Imaging, Lausanne,
Switzerland, 9Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital, Lausanne, Switzerland
Introduction: Computed tomography (CT) is currently the reference modality for the
detection and follow-up of pulmonary nodules. While 2D measurements are commonly
used in clinical practice to assess growth, increasingly 3D volume measurements are
being recommended. The goal of this pilot study was to evaluate preliminarily the
capabilities of 3D MRI using ultra-short echo time for lung nodule volumetry, as it would
provide a radiation-free modality for this task.
Material andMethods: Artificial nodules were manufactured out of Agar andmeasured
using an ultra-short echo time MRI sequence. CT data were also acquired as a reference.
Image segmentation was carried out using an algorithm based on signal intensity
thresholding (SIT). For comparison purposes, we also performed manual slice by slice
segmentation. Volumes obtained with MRI and CT were compared. Finally, the volumetry
of a lung nodule was evaluated in one human subject in comparison with CT.
Results: Using the SIT technique, minimal bias was observed between CT and MRI
across the entire range of volumes (2%) with limits of agreement below 14%. Comparison
of manually segmented MRI and CT resulted in a larger bias (8%) and wider limits of
agreement (−23% to 40%). In vivo, nodule volume differed of <16% between modalities
with the SIT technique.
Conclusion: This pilot study showed very good concordance between CT and
UTE-MRI to quantify lung nodule volumes, in both a phantom and human setting. Our
results enhance the potential of MRI to quantify pulmonary nodule volume with similar
performance to CT.
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INTRODUCTION
Thoracic computed tomography (CT) is the current reference
imaging modality for the detection of nodules as well as for
the follow-up of indeterminate pulmonary nodules incidentally
discovered or occurring in a malignancy context. While 2D
measurements are typically used in clinical practice, 3D volume
measurements are growing in importance due to evidence that
3D volumetry is more robust and improves reproducibility (1).
In the NELSON study, the use of CT volumetry diminished
the need for follow-up evaluation in participants with an
indeterminate test result. More precisely, the strategy entailed the
use of the volume and volume-doubling time (VDT) for non-
calcified indeterminate nodules between 50 and 500 mm3 (i.e.,
4.6–9.8mm in diameter). Growth was defined as an increase
in volume of at least 25% between two scans (2), and a
VDT<400 days was the main criteria suggestive of malignancy
(3). The threshold of 25% was determined accounting for the
substantial variation of semi-automated volume measurements
of pulmonary nodules, the segmentation representing the most
important factor contributing to measurement variability (4).
Although strategies for CT dose reduction have been applied, a
radiation-free modality would be welcome for these tasks and the
detection rate of lung nodules usingMRI has been investigated in
several studies. Good sensitivities for nodules of 4mm and larger
have been obtained owing to the development of new sequences
improving image quality (5) with good signal and contrast-to-
noise ratios, along with improved spatial resolutions (about 1mm
isotropic voxels) (6–10).
In a recent study, excellent performance of 3D radial
ultra-short echo time (UTE) imaging at 3T was reported
for the evaluation of lung nodules (11). A sensitivity of
92.4% was achieved for the detection of solid and subsolid
nodules >4mm, along with high diagnostic properties and
interreader agreement for nodule morphologic assessment.
However, UTE-MRI systematically underestimated dimension
measurements by ∼1–2mm (11). According to the authors, if
the tendency to systematically underestimate dimensions is taken
into account when evaluating UTE-MRI studies, the bias could
be compensated, potentially allowing UTE-MRI to substitute
or complement thin-section CT for evaluating nodule size in
routine clinical practice.
Despite the increased interest of volumetry with CT, no
evaluation has, to our knowledge, been performed using MRI. In
this preliminary work, we evaluated the feasibility of UTE-MRI
volumetry in comparison with low-dose CT on artificial nodules
and one in vivo data set.
MATERIALS AND METHODS
MRI Segmentation Technique
A signal intensity threshold segmentation technique (12–14)
was implemented to carry out segmentation on MRI images
with Slicer 4.8.1 (http://www.slicer.org) (15) as follows: First, a
spherical region of interest (ROI) was manually defined around
each nodule. The ROI size was chosen so as to include the entire
nodule plus an adequate margin of air around it. Within the
ROI, the maximum (Imax) and minimum (Imin) voxel intensity
were recorded. All voxels with signal intensity between Imax and
C · (Imax − Imin) + Imin were then considered part of the
nodule. C is a variable percentage threshold which adjusts the
lower bound of signal intensity for included voxels. With this
equation, if C is equal to 0% all voxels within the ROI will be
selected. As the value of C is increased, voxels with lower signal
intensities will be discarded from the selection.
Phantom Study
Artificial nodules were manufactured out of Agar (30 g/L)
(16) by micropipetting different quantities of hot Agar into
a mold fabricated from the hemispherically shaped part of a
plastic pipette reservoir. After cooling, each artificial nodule was
removed from the mold and weighed on a precision scale. The
weight was then divided by the density of the Agar preparation
to obtain the true volume of each artificial nodule. Twenty-two
artificial nodules with a range of volumes between 16 and 561
mm3 were manufactured.
Imaging was performed within 4 h after manufacturing the
artificial nodules. For imaging, the artificial nodules were placed
between two layers of packing foam, which provided many
interfaces with air to mimic lung parenchyma. A large cylindrical
phantom with two compartments of agar was placed on top of
the setup to provide sufficient MRI coil loading.
MRI acquisition was carried out on a 3T scanner
(MAGNETOM Prisma, Siemens Healthcare, Erlangen,
Germany) using a prototype double echo UTE sequence
(17, 18) with spiral phyllotaxis trajectory (19). The following
acquisition parameters were used: echo time (TE1) = 0.08ms,
TE2 = 2.86ms, TR = 5.9ms, readout bandwidth1 = 305
Hz/pixel, readout bandwidth2 = 610 Hz/pixel, radio-frequency
excitation angle = 5◦, field of view = (500mm)3, matrix size =
5123, voxel size = (0.98mm)3, and 1,220 segments consisting of
50 readouts each. Images were reconstructed using non-uniform
fast Fourier transform.
CT acquisition was performed on a clinical scanner
(Discovery 750 HD, GE Healthcare, Chicago, United States)
using a low-dose protocol (computed tomography dose index of
2) with 1.25mm thick overlapped slices reconstructed with soft
kernel, as recommended for accurate segmentation (20).
Nodules were segmented on MRI images using the signal
intensity threshold algorithm outlined above. Multiple values
were compared for the threshold C (20, 30, 40, and 50%) to
determine the one which results in the highest concordance
with the known volume. In addition, segmentation was also
carried out on MRI images by a chest imaging expert who traced
manually the outline of each artificial nodule on each slice using
the “Live Wire” mode of the “Lesion Management” module of
our PACS system (Carestream, Rochester, New York, USA). CT
image segmentation was carried out using the automatic CT lung
lesion segmentation tool from the same module.
In vivo Feasibility Study
We also compared the CT and UTE-MR volumetric assessment
of a real nodule incidentally detected in the upper part of
the right upper lobe of a volunteer from a recent study that
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explored a new technique allowing prolonged apnea-like MR
acquisition performed at full inspiration (21). UTE acquisition
was carried out during a 6-min long respiratory stabilization
period. This study was carried out in accordance with the
recommendations of the “Commission cantonale (VD) d’éthique
de la recherche sur l’être humain” with written informed consent
from all subjects. All subjects gave written informed consent
in accordance with the Declaration of Helsinki. The protocol
was approved by the “Commission cantonale (VD) d’éthique
de la recherche sur l’être humain.” UTE-MR volumetry was
carried out with the same procedure as for artificial nodules.
For the signal intensity thresholding, the value of C that gave
the highest concordance with CT in vitro was used. Nodule
volume was assessed on CT with the software used in routine
practice in our PACS system by using the lung and soft kernel,
the latter being recommended for accurate segmentation (20).
Additionally, average diameter measurement were carried out, as
recommended by the Fleischner Society as the average of long
and short axes more accurately reflects three-dimensional tumor
volume (8).
Statistical Analysis
As in the NELSON study volume doubling times were calculated
only for nodules with volumes>50 mm3, we explicitly excluded
the four artificial nodules with volume<50 mm3 from analysis,
as they would not require a volume doubling time assessment at
this size. X-Y plots were used to compare volume measurements
obtained from phantom MRI data to the values derived from
weight measurements and the ones resulting from CT image
segmentation. Lin’s concordance analysis was carried out to
quantify the relationships. In addition percent-based Bland-
Altman analysis was performed on measurements obtained with
the value of C offering the best correlation to assess the bias and
limits of agreement between MRI and CT in phantoms.
RESULTS
Phantom Study
When comparing MRI volume measurements to the volume
according to the mass of the artificial nodules (Figures 1A–D)
or with CT based volume measurements (Figures 1E,F), in all
cases the Pearson correlation coefficient (ρ) was larger than 0.9.
However, the bias correction factor (Cb) varied between 0.663
and 0.998 depending on the value used for the signal intensity
threshold C. The highest value was obtained with a threshold C
equal to 30%. The best concordance in terms of Lin’s coefficient
(ρc) was also obtained with a threshold for MRI segmentation
equal to 30%.
Bland-Altman analysis between CT and MRI, using signal
intensity threshold segmentation (C = 30%) indicated limits
of agreement below 14% (Figure 2A) with minimal bias (2%)
from the smallest to the largest artificial nodule volumes. When
manual segmentation was used (Figure 2B), a slightly larger bias
(8%) was observed and limits of agreement were wider (−23 to
40%) with respect to CT volume.
In vivo Feasibility Study
On in vivo images, the nodule could be successfully segmented
in MRI data using the investigated signal intensity threshold
technique (Figure 2C). The volume was determined to be 121
mm3, with an average diameter of 6mm. On CT images,
when using the lung kernel, a volume of 110 mm3 was
obtained while with the soft kernel images a value of 104 mm3
(Figure 2D) was reached. In both cases, the average diameter
measured was of 6mm. Hence, the differences in volumes
were of 10% (lung kernel) and 16% (soft kernel) between CT
and MRI segmented using signal intensity threshold. Manual
slice by slice segmentation of the MRI resulted in a larger
volume measurement (146 mm3), with an average diameter
of 6mm. With this manual segmentation, the differences
between CT and MRI were between 33% (lung kernel) and
40% (soft kernel).
DISCUSSION
While demonstrating that MR pulmonary nodule volumetry is
feasible, we observed an inter-modality difference of <20% both
ex-vivo and in-vivo with signal intensity threshold segmentation
when using a parameter C of 30%. This difference, both in
phantoms and in vivo, remains below the threshold of 25% that
defines a change in nodule volume between two examinations (2).
Therefore, our results suggest that 3D-UTE-MRI could be used as
an alternative to low-dose 3D-CT for pulmonary nodule volume
evaluation. This could drastically reduce population exposure to
CT related irradiation.
With the lowest signal intensity threshold C = 20% the
volume measured in phantoms was overestimated, as could be
appreciated graphically (Figures 1A,E). Values of 40% and 50%
on the other hand resulted in underestimation of the volume
(Figures 1C,D,G,H) as not enough lower intensity voxels were
included in the segmentation. The optimal value was found to be
30% (Figures 1B,F) as it resulted in excellent correlation (ρc =
0.984 and ρc = 0.994), precision (ρ = 0.996 and ρ = 0.996) as
well as minimal bias (Cb = 0.988 and Cb = 0.998).
While artificial nodules were surrounded by foam, the
background signal in true lung parenchyma is expected to be
higher. This could potentially make segmentation more difficult
as the signal transition may be less well-defined between nodules
and the surrounding parenchyma. However, with the in vivo
case evaluated in this feasibility study, volumetry was still
consistent between CT and MRI despite the presence of such
parenchymal signal. To generalize this finding, the robustness
of the method needs confirmation on a large cohort including
both solid and subsolid nodules. This work is still ongoing
in our institution. The concordance of volume doubling time
across modalities should also be investigated. Furthermore, the
potential influence of gadolinium injection also requires further
assessment. The impact of the MR signal intensity threshold (i.e.,
30%) on volumetric variability across MR manufacturers or UTE
variants should also be evaluated since it could be a limitation in
multicenter studies.
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FIGURE 1 | Lin’s concordance analysis between artificial nodule volumes measured on UTE MRI data relative to mass derived volume measurements for increasing
values of C. Dashed line is the line of equality. Solid line indicates reduced major axis linear regression. (A) C = 20%, (B) C = 30%, (C) C = 40%, (D) C = 50%.
Pearson correlation (ρ) was larger than 0.9 with all values while the bias correction factor (Cb) varied between 0.663 and 0.988. The deviation from the line of equality
could also be appreciated. Comparison between CT and UTE MRI showed similar results, as seen in (E) C = 20%, (F) C = 30%, (G) C = 40%, and (H) C = 50%.
Excellent precision (ρ = 0.996) and minimal bias between measurement methods (Cb = 0.998) was observed for a value of C = 30%.
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FIGURE 2 | (A) Bland-Altman plot comparing CT and UTE MRI (signal intensity threshold C = 30%) based volume measurements of artificial nodules. Differences are
expressed as percentage. Minimal bias was observed across the entire range of volumes (2%) with limits of agreement below 14% (−10% to 14%). (B) Comparison of
CT and manually segmented MRI of artificial lung nodules. A slightly larger bias (8%) was observed and limits of agreement were wider (−23% to 40%).
(C) Segmentation of lung nodule in a volunteer on UTE MRI image using threshold based segmentation in Slicer. (D) Segmentation of the same lung nodule on CT
image reconstructed with soft kernel using semi-automatic segmentation tool.
The only manual step in the signal intensity threshold
method was the placement of the ROI within which the
thresholding operation should be performed. The reduced
operator dependence should result in high reproducibility of
measurements but future investigations are required to ascertain
this, especially in vivo. In phantoms, manual delineation of
nodule outlines slice by slice was challenging, as due to
partial volume effects and the texture of the nodules, the
boundaries were not clearly defined. This resulted in larger bias
and limits of agreement (Figure 2B) than the objective signal
intensity threshold segmentation technique (Figure 2A). The
procedure studied in this work should also be evaluated using
commercial software from different vendors that also generally
offer threshold segmentation tools. If differences of volumes
measured across platforms remain limited, widespread clinical
use could be enabled.
In our current setting, MRI examination, including patient
installation and image acquisition with a single UTE acquisition,
may be carried out in under 30min. While this is longer than
the time required for a standard CT protocol (∼10min), the
duration remains reasonable for clinical workflow. Both CT and
MRI segmentation took<5min.
A limitation of this study is that only a single, incidentally
discovered, in vivo nodule was available for study. Further
studies are required to explore the impact of nodule texture
and position on MRI volume measurements. In particular, the
reliability of volume measurements close to the lung bases needs
confirmation. Although the respiratory stabilization method
used (21) greatly diminishes motion compared to free-breathing
acquisitions, residual motion artifacts may remain, particularly
at the lung bases. Related to this issue, it also remains to be
ascertained that respiratory stabilization can also be reliably
achieved in patients with lung disease.
In conclusion, this first study shows very good concordance
between CT and UTE-MRI to quantify lung nodule volumes,
in both a phantom and human conditions. In addition to the
already known capabilities of MR to characterize tissue contrasts,
our results enhance the potential of high resolution MRI to also
quantify pulmonary nodule volume with similar performance to
that of CT. Future assessment in a larger cohort may eventually
promoteMRI as a powerful and reproducible tool for lung nodule
management, especially in the setting of indeterminate nodules
that would require repetition of imaging and/or more specific
evaluation, in a radiation-free manner.
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